Joint effect of self-reported sleep problems and three components of the metabolic syndrome on risk of coronary heart disease

Journal of Psychosomatic Research

Volumn 68, Issue 2, 2010, Pages 149-158

  Loponen, Minna ^a,b   Hublin, Christer ^c   Kalimo, Raija ^c   Mänttäri, Matti ^d,e   Tenkanen, Leena ^a,b  

^a UNIVERSITY OF TAMPERE   (Finland)

^b Helsinki Heart Study   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d JORVI HOSPITAL   (Finland)

^e WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Coronary heart disease; Joint effect; Metabolic syndrome; Public health; Sleep problems

Indexed keywords

GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; EPIDEMIC; FATIGUE; HUMAN; INSOMNIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PUBLIC HEALTH PROBLEM; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SELF REPORT; SLEEP DISORDER;

CORONARY DISEASE; FINLAND; HUMANS; MALE; METABOLIC SYNDROME X; QUESTIONNAIRES; REGISTRIES; RISK; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 73549085127     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.07.022     Document Type: Article

References (50)

1. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6 (2002) 97-111
2. Soldatos C.R., Allaert F.A., Ohta T., et al. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Medicine 6 (2005) 5-13
3. Doghramji K. The epidemiology and diagnosis of insomnia. Am J Manag Care 12 (2006) 214-220
4. Wolk R., Gami A.S., Garcia-Touchard A., et al. Sleep and cardiovascular disease. Curr Probl Cardiol 30 (2005) 625-662
5. Somers V.K., White D.P., Amin R., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118 (2008) 1080-1111
6. Ferrie J.E., Shipley M.J., Cappuccio F.P., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II Cohort. Sleep 30 (2007) 1659-1666
7. Hublin C., Partinen M., Koskenvuo M., et al. Sleep and mortality: a population-based 22-year follow-up study. Sleep 30 (2007) 1245-1253
8. Elwood P., Hack M., Pickering J., et al. Sleep problem, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 60 (2006) 69-73
9. Marin J.M., Carrizo S.J., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
10. Schenck C.H., Mahowald M.W., and Sack R.L. Assessment and management of insomnia. JAMA 289 (2003) 2475-2479
11. Walsh J.K., and Engelhardt C.L. The direct economic costs of insomnia in the United States for 1995. Sleep 22 (1999) 386-393
12. Fry J., and Finley W. The prevalence and costs of obesity in the EU. Proc Nutr Soc 64 (2005) 359-362
13. Haslam D.W., and James W.P. Obesity. Lancet 366 (2005) 1197-1209
14. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
15. Grundy S.M., Brewer H.B., Cleeman J.I., et al. Definition of metabolic syndrome: report of the national Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109 (2004) 433-438
16. Grundy S.M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28 (2008) 629-636
17. Batsis J.A., Nieto-Martinez R.E., and Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 82 (2007) 509-524
18. Grundy S.M. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47 (2006) 1093-1100
19. Wolk R., and Somers V.K. Sleep and metabolic syndrome. Exp physiol 92 (2007) 67-78
20. Choi K.M., Lee J.S., Park H.S., et al. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes 32 (2008) 1091-1097
21. Hall M.H., Muldoon M.F., Jennings J.R., et al. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 3 (2008) 635-643
22. Jennings J.R., Muldoon M.F., Hall M., et al. Self-reported sleep quality is associated with the metabolic syndrome. Sleep 30 (2007) 219-223
23. Knutson K.L., Spiegel K., Penev P., et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 11 (2007) 163-178
24. Coughlin S.R., Mawdsley L., Mugarza J.A., et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 (2004) 735-741
25. Bjorvatn B., Sagen I., Øyane N., et al. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res 16 (2007) 66-76
26. Vorona R.D., Winn M.P., Babineau T.W., et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 165 (2005) 25-30
27. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., et al. Short sleep duration as a risk factor for hypertension: analyses of the First National Health and Nutrition Examination Survey. Hypertension 47 (2006) 833-839
28. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 84 (1999) 2603-2607
29. Grundy SM. Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92 (2007) 399-404
30. Liu J., Grundy S.M., Wang W., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J 153 (2007) 552-558
31. Kalimo R., Tenkanen L., Härmä M., et al. Job stress and sleep disorders: findings from the Helsinki Heart Study. Stress Med 16 (2000) 65-75
32. Tenkanen L., Mänttäri M., and Manninen V. Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study. Circulation 92 (1995) 1779-1785
33. Pietilä K., Tenkanen L., Mänttäri M., et al. How to define coronary heart disease in register-based follow-up studies: experience from the Helsinki Heart Study. Ann Med 29 (1997) 253-259
34. Kleitman N. Sleep and Wakefulness (1963), University of Chicago Press, Chicago
35. Frick M.H., Elo O., Haapa K., et al. The Helsinki Heart Study: primary prevention trial with gemfibrozil middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317 (1987) 1237-1245
36. Sateia M., and Nowell P. Insomnia. Lancet 364 (2004) 1959-1973
37. Ohayon M. From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev 12 (2008) 129-141
38. Summers M., Crisostomo M., and Stepanski E. Recent developments in the classification, evaluation, and treatment of insomnia. Chest 130 (2006) 276-286
39. Phillips M., and Mannino D. Does insomnia kill?. Sleep 28 (2005) 965-971
40. Hublin C., Kaprio M., Partinen M., et al. Daytime sleepiness in an adult, Finnish population. J Intern Med 239 (1996) 417-423
41. Ohayon M., and Partinen M. Insomnia and global dissatisfaction in Finland. J Sleep Res 11 (2002) 339-346
42. Hublin C., Kaprio J., Partinen M., et al. Insufficient sleep-a population-based study in adults. Sleep 24 (2001) 392-400
43. Taheri S., Lin L., Austin D., et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1 (2004) 210-217
44. Chasens E.R. Obstructive sleep apnea, daytime sleepiness, and type 2 diabetes. Diabetes Educ 33 (2007) 475-482
45. Kraja A., Province M., Arnett D., et al. Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?. Nutr Metab 4 (2007) 28
46. Roivainen M., Viik-Kajander M., Palosuo T., et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 101 (2000) 252-257
47. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
48. Meier-Ewert H.K., Ridker P.M., Rifai N., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43 (2004) 678-683
49. von Känel R., Loredo J.S., Ancoli-Israel S., et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 131 (2007) 733-739
50. Manninen V., Huttunen J.K., Tenkanen L., et al. High density lipoprotein cholesterol as a risk factor for coronary heart disease in the Helsinki Heart Study. In: Miller N.E. (Ed). High-density lipoproteins, reverse cholesterol transport, and coronary heart disease (1989), Excerpta Medica 76-84